The FDA's decision to fully license the Pfizer-BioNTech COVID-19 vaccine is expected to trigger more mandates and allow marketing of the shot.
USA TODAY, Statesman Journal
Mon, 08/23/2021 - 9:22am
The FDA's decision to fully license the Pfizer-BioNTech COVID-19 vaccine is expected to trigger more mandates and allow marketing of the shot.